跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
孟鲁司特钠片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Montelukast Sodium Tablets
Approved
化学药品
Montelukast Sodium Tablets
SANDOZ PRIVATE LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Nov 3, 2021
Approval ID
8CYnSMaPPb2
Company
SANDOZ PRIVATE LIMITED
Type
化学药品
Approval Details
Approval Id
8CYnSMaPPb2
Approval Number
国药准字HJ20210076
Generic Name
孟鲁司特钠片
Generic Name En
Montelukast Sodium Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
10mg(按C₃₅H₃₆ClNO₃S计)
Reg Date
2021-11-03
Expired Date
2026-11-02
Company Name
SANDOZ PRIVATE LIMITED
Production Company Name
SANDOZ PRIVATE LIMITED
Company Detail Path
/organization/sandoz-private-limited
Production Company Detail Path
/organization/sandoz-private-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 3, 2021
Approval ID
8CYnSMaPPb2
Type
化学药品
Back to NMPA Approvals